Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 281

1.

Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis.

Caruso M, Cibella F, Emma R, Campagna D, Tringali G, Amaradio MD, Polosa R.

Int Immunopharmacol. 2018 Jul;60:50-58. doi: 10.1016/j.intimp.2018.04.034. Epub 2018 Apr 25.

PMID:
29702283
2.

Frequency of Use and Smoking Status of U.S. Adolescent E-Cigarette Users in 2015.

Farsalinos K, Tomaselli V, Polosa R.

Am J Prev Med. 2018 Jun;54(6):814-820. doi: 10.1016/j.amepre.2018.03.003. Epub 2018 Apr 7.

PMID:
29631871
3.

Treatment of Allergic Rhinitis as a Strategy for Preventing Asthma.

Morjaria JB, Caruso M, Emma R, Russo C, Polosa R.

Curr Allergy Asthma Rep. 2018 Mar 24;18(4):23. doi: 10.1007/s11882-018-0781-y. Review.

PMID:
29574527
4.

Lack of Substantial Post-Cessation Weight Increase in Electronic Cigarettes Users.

Russo C, Cibella F, Mondati E, Caponnetto P, Frazzetto E, Caruso M, Caci G, Polosa R.

Int J Environ Res Public Health. 2018 Mar 23;15(4). pii: E581. doi: 10.3390/ijerph15040581.

5.

E-Cigarette and COPD: Unreliable Conclusion About Health Risks.

Cummings KM, Polosa R.

J Gen Intern Med. 2018 Jun;33(6):784-785. doi: 10.1007/s11606-018-4396-8. No abstract available.

PMID:
29564607
6.

Assessment of E-cigarette impact on smokers: The importance of experimental conditions relevant to human consumption.

Li Volti G, Polosa R, Caruso M.

Proc Natl Acad Sci U S A. 2018 Apr 3;115(14):E3073-E3074. doi: 10.1073/pnas.1801967115. Epub 2018 Mar 13. No abstract available.

PMID:
29535226
7.

Training pharmacists in the stage-of-change model of smoking cessation and motivational interviewing: A randomized controlled trial.

Caponnetto P, DiPiazza J, Aiello MR, Polosa R.

Health Psychol Open. 2017 Oct 28;4(2):2055102917736429. doi: 10.1177/2055102917736429. eCollection 2017 Jul-Dec.

8.

E-cigarettes unlikely to raise significant health concerns in airways disease.

Polosa R.

Respirology. 2018 Apr;23(4):435-436. doi: 10.1111/resp.13256. Epub 2018 Jan 9. No abstract available.

PMID:
29316603
9.

Biologic agents for severe asthma patients: clinical perspectives and implications.

Caruso M, Morjaria J, Emma R, Amaradio MD, Polosa R.

Intern Emerg Med. 2018 Mar;13(2):155-176. doi: 10.1007/s11739-017-1773-y. Epub 2017 Dec 14. Review.

PMID:
29238905
10.

Are we addressing relevant determinants of smoking cessation?

Caponnetto P, Polosa R.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701615. doi: 10.1183/13993003.01615-2017. Print 2017 Nov. No abstract available.

PMID:
29167305
11.

Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked.

Polosa R, Cibella F, Caponnetto P, Maglia M, Prosperini U, Russo C, Tashkin D.

Sci Rep. 2017 Nov 17;7(1):13825. doi: 10.1038/s41598-017-14043-2.

12.

E-cigarettes in patients with COPD: current perspectives.

Morjaria JB, Mondati E, Polosa R.

Int J Chron Obstruct Pulmon Dis. 2017 Nov 1;12:3203-3210. doi: 10.2147/COPD.S135323. eCollection 2017. Review.

13.

Perplexing Conclusions Concerning Heat-Not-Burn Tobacco Cigarettes.

Caruso M, Polosa R.

JAMA Intern Med. 2017 Nov 1;177(11):1699. doi: 10.1001/jamainternmed.2017.5843. No abstract available.

PMID:
29114793
14.

Letter to the Editor: Pulmonary toxicity of electronic cigarettes: more doubts than certainties.

Caruso M, Mendelsohn CP, Polosa R.

Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L964-L965. doi: 10.1152/ajplung.00402.2017. No abstract available.

PMID:
29109109
15.

A review article on biosimilar infliximab SB2 in the treatment of rheumatoid arthritis.

Bellinvia S, Ashraf M, Polosa R, Edwards C.

Immunotherapy. 2017 Nov;9(14):1133-1142. doi: 10.2217/imt-2017-0068. Epub 2017 Sep 18. Review.

PMID:
29067885
16.

Scientific and ethical obligations to publish tobacco industry-funded research on nicotine delivery systems of reduced risk.

Polosa R, Crawley FP.

Toxicology. 2017 Sep 1;390:61-62. doi: 10.1016/j.tox.2017.09.003. Epub 2017 Sep 4. No abstract available.

PMID:
28882573
17.

A critique of the US Surgeon General's conclusions regarding e-cigarette use among youth and young adults in the United States of America.

Polosa R, Russell C, Nitzkin J, Farsalinos KE.

Harm Reduct J. 2017 Sep 6;14(1):61. doi: 10.1186/s12954-017-0187-5.

18.

Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis.

Sambataro G, Sambataro D, Polosa R.

Ther Adv Chronic Dis. 2017 Jun;8(6-7):97-99. doi: 10.1177/2040622317702363. Epub 2017 May 10. No abstract available.

19.

Erratum to: Analysis of E-cigarette use in the 2014 Eurobarometer survey: calling out deficiencies in epidemiology methods.

Polosa R, Caponnetto P, Niaura R, Abrams D.

Intern Emerg Med. 2017 Sep;12(6):907. doi: 10.1007/s11739-017-1685-x. No abstract available.

20.

Analysis of E-cigarette use in the 2014 Eurobarometer survey: calling out deficiencies in epidemiology methods.

Polosa R, Caponnetto P, Niaura R, Abrams D.

Intern Emerg Med. 2017 Sep;12(6):733-735. doi: 10.1007/s11739-017-1667-z. Epub 2017 May 5. No abstract available. Erratum in: Intern Emerg Med. 2017 Sep;12 (6):907.

Supplemental Content

Loading ...
Support Center